Phenominer Database Results (14 hits)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum triglyceride level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood triglyceride amount male 218 days 11 111.7 mg/dl 8.83 29.29 serum triglyceride analysis 0.0 0 Wako Pure Chemicals, Tokyo, Japan 13195 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 11 87.7 mg/dl 3.2 10.61 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12798 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj mesenteric fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. mesenteric fat pad mass male 218 days 11 1.81 % 0.07 0.23 post excision weight measurement 0.0 0 67470 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 11 5.82 ng/ml 0.59 1.96 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67486 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum total cholesterol level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood cholesterol amount male 218 days 11 76.2 mg/dl 1.79 5.94 serum total cholesterol measurement test 0.0 0 Wako Pure Chemicals, Tokyo, Japan 12799 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj retroperitoneal fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. retroperitoneal fat pad mass male 218 days 11 8.8 g 0.3 0.99 post excision weight measurement 0 12801 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj epididymal fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. epididymal fat pad mass male 218 days 11 8.8 g 0.3 0.99 post excision weight measurement 0 12802 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 11 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67478 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 11 423.2 g 7.3 24.21 body weighing method 0.0 oral glucose 0 min 12803 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj retroperitoneal fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. retroperitoneal fat pad mass male 218 days 11 8.8 % 0.3 0.99 post excision weight measurement 0.0 0 67474 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj epididymal fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. epididymal fat pad mass male 218 days 11 2.08 % 0.05 0.17 post excision weight measurement 0.0 0 67494 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum free fatty acids level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood free fatty acid amount male 218 days 11 0.68 mmol/l 0.05 0.15 serum free fatty acid analysis 0.0 0 Wako Pure Chemicals, Tokyo, Japan 67498 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj mesenteric fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. mesenteric fat pad mass male 218 days 11 7.6 g 0.3 0.99 post excision weight measurement 0 12800 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum adiponectin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood adiponectin amount male 211 days 11 2.75 ng/ml 0.2 0.66 enzyme linked immunosorbent assay 0.0 0 ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67482 311